HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, March 2014

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

About Medical Imaging, 25 Feb 2015

Related Articles HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based…